glutathione rapta c Anticancer activity of RAPTA-EA1 in triple-negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib The development of RAPTA compounds
The development of RAPTA compounds for the treatment of tumors ScienceDirect Structures of RAPTA C (a), RAPTA T (b) Download Scientific Diagram Combinative Treatment of the PARP Inhibitor Olaparib and Antimetastasis Ruthenium(II)Arene Compound RAPTA T for Triple Negative BRCA1 Wild Type Breast Cancer Cells Structures of RAPTA C and of a generic RANHC. Download Scientific Diagram Glutathione binding to dirhodium tetraacetate: a spectroscopic, mass spectral and computational study of an anti tumour compound Metallomics (RSC Publishing) DOI:10.1039 C7MT00040E RAPTA C (Ru(6 p cymene)Cl2(pta)) Anti cancer Agent, Anti angiogenic Agent MedChemExpress
Pay in 4 interest-free payments of $6.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





